Bioprocess development for cord blood mesenchymal stromal cells on microcarriers in Vertical‐Wheel bioreactors
Biotechnology and Bioengineering · 2024
DOI: 10.1002/bit.28557 ↗At a glance
Journal article in Biotechnology and Bioengineering, 2024. Written by Erin L Roberts and 3 co-authors. Institution: Pharmaceutical Production Research Facility, Schulich School of Engineering, University of Calgary, Calgary, Alberta, Canada. Major MEDLINE topics: Cell Culture Techniques, Mesenchymal Stem Cells. Cited 3 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Ontario Agri-Food Innovation Alliance, Natural Sciences and Engineering Research Council of Canada.
Abstract (original language)
Equine mesenchymal stromal cells (MSCs) have been found to be beneficial for the treatment of many ailments, including orthopedic injuries, due to their superior differentiation potential and immunomodulating properties. Cell therapies require large cell numbers, which are not efficiently generated using conventional static expansion methods. Expansion of equine cord blood‐derived MSCs (eCB‐MSCs) in bioreactors, using microcarriers as an attachment surface, has the potential to generate large numbers of cells with increased reproducibility and homogeneity compared with static T‐flask expansion. This study investigated the development of an expansion process using Vertical‐Wheel (VW) bioreactors, a single‐use bioreactor technology that incorporates a wheel instead of an impeller. Initially, microcarriers were screened at small scale to assess eCB‐MSC attachment and growth and then in bioreactors to assess cell expansion and harvesting. The effect of different donors, serial passaging, and batch versus fed batch were all examined in 0.1 L VW bioreactors. The use of VW bioreactors with an appropriate microcarrier was shown to be able to produce cell densities of up to 1E6 cells/mL, while maintaining cell phenotype and functionality, thus demonstrating great potential for the use of these bioreactors to produce large cell numbers for cell therapies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Pharmaceutical Production Research Facility, Schulich School of Engineering, University of Calgary, Calgary, Alberta, Canada.
- Department of Biomedical Engineering, Schulich School of Engineering, University of Calgary, Calgary, Alberta, Canada.
- Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
ORCID profiles: Michael S Kallos
Funding
- Ontario Agri-Food Innovation Alliance
- Natural Sciences and Engineering Research Council of Canada
Cite
APA
Roberts, E. L., Lepage, S. I. M., Koch, T. G., & Kallos, M. S. (2024). Bioprocess development for cord blood mesenchymal stromal cells on microcarriers in Vertical‐Wheel bioreactors. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28557
Vancouver
Roberts EL, Lepage SIM, Koch TG, Kallos MS. Bioprocess development for cord blood mesenchymal stromal cells on microcarriers in Vertical‐Wheel bioreactors. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28557
BibTeX
@article{Roberts2024,
author = {Roberts, Erin L and Lepage, Sarah I M and Koch, Thomas G and Kallos, Michael S},
title = {Bioprocess development for cord blood mesenchymal stromal cells on microcarriers in Vertical‐Wheel bioreactors},
journal = {Biotechnology and Bioengineering},
year = {2024},
doi = {10.1002/bit.28557}
}
EUVIMED